Testosterone replacement therapy: What we know is not yet enough

Mayo Clinic Proceedings

Volumn 82, Issue 1, 2007, Pages 11-13

  Isidori, Andrea M ^a   Lenzi, Andrea ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTROGEN; TESTOSTERONE;

ANDROGEN BLOOD LEVEL; ANDROGEN DEFICIENCY; BODY FAT; DEATH; DISEASE ASSOCIATION; DRUG POTENCY; DRUG SAFETY; EDITORIAL; ERECTILE DYSFUNCTION; HEART INFARCTION; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; LEAN BODY WEIGHT; LIBIDO; MALE; PATIENT SATISFACTION; PENIS ERECTION; SEXUAL FUNCTION; SIDE EFFECT; SYMPTOMATOLOGY;

EID: 33845926887     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/82.1.11     Document Type: Editorial

References (15)

1. Liverman CT, Blazer DG, eds. Testosterone and Aging: Clinical Research Directions. Washington, DC: National Academies Press; 2004.
2. Isidori AM, Giannetta E, Greco EA, et al. Effects of testosterone on body composition, bone metabolism and serum lipid profile in middle-aged men: a meta-analysis. Clin Endocrinol (Oxf). 2005;63:280-293.
3. Isidori AM, Giannetta E, Gianfrilli D, et al. Effects of testosterone on sexual function in men: results of a meta-analysis. Clin Endocrinol (Oxf). 2005;63:381-394.
4. Liu PY, Wang C, Swerdloff RS. Male sex matters. Clin Endocrinol (Oxf). 2005;63:601-602.
5. Tracz MJ, Sideras K, Bolona ER, et al. Testosterone use in men and its effects on bone health: a systematic review and meta-analysis of randomized placebo-controlled trials. J Clin Endocrinol Metab. 2006 Jun;91:2011-2016. Epub 2006 May 23.
6. Haddad RM, Kennedy CC, Caples SM, et al. Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc. 2007;82:29-39.
7. Boloña ER, Uraga MV, Haddad RM, et al. Testosterone use in men with sexual dysfunction: a systematic review and meta-analysis of randomized placebo-controlled trials. Mayo Clin Proc. 2007;82:20-28.
8. Isidori AM, Giannetta E, Pozza C, Bonifacio V, Isidori A. Androgens, cardiovascular disease and osteoporosis. J Endocrinol Invest. 2005;28(10, suppl):73-79.
9. English KM, Steeds RP, Jones TH, Diver MJ, Channer KS. Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: a randomized, double-blind, placebo-controlled study. Circulation. 2000;102:1906-1911.
10. Pugh PJ, Jones TH, Channer KS. Acute haemodynamic effects of testosterone in men with chronic heart failure. Eur Heart J. 2003;24:909-915.
11. Malkin CJ, Pugh PJ, West JN, van Beek EJ, Jones TH, Channer KS. Testosterone therapy in men with moderate severity heart failure: a double-blind randomized placebo controlled trial. Eur Heart J. 2006 Jan;27:57-64. Epub 2005 Aug 10.
12. Morelli A, Filippi S, Mancina R, et al. Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa [published correction appears in Endocrinology. 2004;145:3152]. Endocrinology. 2004 May;145:2253-2263. Epub 2004 Feb 5.
13. Aversa A, Isidori AM, Spera G, Lenzi A, Fabbri A. Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction. Clin Endocrinol (Oxf). 2003;58:632-638.
14. Nieschlag E, Swerdloff R, Behre HM, et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, and EAU recommendations. Int J Androl. 2005;28:125-127.
15. McKinlay JB. Should we begin a large clinical trial of testosterone in men? "not yet." JMHG. 2006;3:33-35.